Junshi Biosciences Announces Ongericimab (anti-PCSK9 mAb) Met Primary Endpoints in Two Phase 3 Clinical Studies
Globe Newswire28-02-2023, 11:50
TMC and PAMCO Sign Binding MOU to Complete Feasibility Study to Process Polymetallic Nodules into Battery Metal Feedstocks 13-11-2023, 19:00